VAERS Explorer
Back to explore

Report #2826900

Received Feb 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
MD
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
HEPAHEP A (HAVRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——
HEPAHEP A (HAVRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (2)

Inappropriate schedule of product administrationUnderdose

Symptom narrative

Havrix - Pediatric dose to an adult; underdose; Havrix - Pediatric dose to an adult; underdose; drug dose administrartion interval too short; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 43-year-old female patient who received HAV (Havrix pediatric) for prophylaxis. Co-suspect products included HAV (Havrix pediatric) for prophylaxis. On an unknown date, the patient received Havrix pediatric and Havrix pediatric. On an unknown date, an unknown time after receiving Havrix pediatric and not applicable after receiving Havrix pediatric, the patient experienced adult use of a child product (Verbatim: Havrix - Pediatric dose to an adult), underdose (Verbatim: underdose), adult use of a child product (Verbatim: Havrix - Pediatric dose to an adult), underdose (Verbatim: underdose) and drug dose administration interval too short (Verbatim: drug dose administrartion interval too short). The outcome of the adult use of a child product, underdose, adult use of a child product, underdose and drug dose administration interval too short were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-JAN-2025 A medical assistant reported that an adult patient received a Havrix pediatric dose and one month later the patient received another pediatric dose. The medical assistant asked if they should re start the series. The reporter did not provide any information about the 2 pediatric Havrix doses. The adult patient received Havrix pediatric dose, which led to adult use of a child product and underdose. The patient received another dose of Havrix pediatric, earlier than the recommended interval, which led to shortening of vaccinations schedule.